Cardiocast

AHA statement on statin risks, app that diagnoses STEMI, and more


 

This week, the American Heart Association says that statins’ benefits far outweigh the risks, a smartphone app is nearly as good as an ECG at diagnosing STEMI, stroke thrombolysis appears safe in patients prone to GI bleeding, and a new strategy for pausing DOAC therapy works in A-fib patients.

Subscribe to Cardiocast wherever you get your podcasts.
Amazon Alexa
Apple Podcasts

Recommended Reading

Revised U.S. cholesterol guidelines promote personalized risk assessment
MDedge Internal Medicine
NASH drug passes phase 2 trial
MDedge Internal Medicine
Risk of cancer in NAFLD is 91% higher than in control subjects
MDedge Internal Medicine
Empagliflozin reduces left ventricular mass
MDedge Internal Medicine
‘Phenomenal’ REDUCE-IT establishes triglyceride theory
MDedge Internal Medicine
Routine markers predicted histologic response to obeticholic acid in NASH
MDedge Internal Medicine
Visual representation of atherosclerosis helps reduce cardiovascular risk
MDedge Internal Medicine
Combined novel risk factors raise coronary event rates
MDedge Internal Medicine
Study investigates statin-diabetes link
MDedge Internal Medicine
AHA: Statins associated with high degree of safety
MDedge Internal Medicine